Micron's Reality Check: When Good News Isn't Enough
Torm Investors Face a November 25 Deadline That Matters More Than Hafnia's Retreat
Airbus Sticks to 2026 Delivery Target as Buyback, Cathay Order and EASA Directive Converge
Amazon's AI Ledger: A 15% Anthropic Stake, a 600-Megawatt Power Deal and a Black Friday Push
Take-Two's GTA VI Math: Wells Fargo Doubles Its Bet, but the PC Question Still Hangs Over It
2G Energy's Order Intake Hits 885.9 Million Euros as Cash and Hardware Start Moving on 275 MW Deal
BASF's Evonik Courtship Stalls as WĂĽst Voices Opposition and Jefferies Turns Bearish
Deutsche Telekom Marks Three Decades on the Market While Buyback and Analyst Signals Diverge
Mutares Refinances 2027 Notes With EUR 165 Million Tap While Divesting Magirus and Guascor
Steyr Motors' €39 Question: A Bidder's Stumble Is Not the Deal's Demise
BMW Wraps €2 Billion Buyback as Battery Deals and Parts Shortages Reshape the Story
Nebius Stock: A $27 Billion Capex Bill, a Halved Target, and the 2027 Revenue That Has to Show Up
Vulcan Energy Adds Landau-Ost to Its Pipeline While Lionheart Enters Civil Construction
D-Wave Quantum: A Gartner Nod, a 21% Revenue Gain and the Margin That Slipped to 52.9%
SanDisk Locks In 80% Margins on Eight Cloud Deals While Wall Street Trims Its AI Enthusiasm
Nvidia's Data-Center Engine Outshines a Leadership Vacuum and a Regulatory Shadow
Powermax Minerals Weighs Fresh Equity Raise Against Unverified Ontario Drill Targets
Deutz Plunges 16% as Short Seller Questions Who Really Profits From FFG Deal
CSG's Fourth-Quarter Deliveries Become the Real Test of a Trimmed Margin Story
PFISTERER Lifts Revenue Guidance to Upper Half as Nine-Month Sales Climb 17.5%
Oracle Rolls Out AI Across Project and Clinical Software as Cash Burn Tests the Story
Rheinmetall's Robot Pitch Meets a Wall of Cut Price Targets
Nio's Arctic Battery-Swap Milestone Meets a Crowded Field and a Cooling Market
Ballard Power's Losses Shrink Even as Revenue Slips 31%
Volkswagen's Factory Future Carries More Weight Than Any Single Model Launch
OncoclĂnicas stock: Q3 results delayed until December review
Bayer's 51% Rally Faces a February Reckoning as Analyst Bets Diverge
Take-Two's GTA VI Windfall Hinges on a PC Date Nobody Has Confirmed
Sellas Life Sciences: A Survival Benefit, a Clean Safety Read, and the Equity Question in Between
NovaBridge stock: Visara starts ASCEND trial in wet AMD
Wells Fargo upgrades Praxis Precision Medicines stock to Overweight
OneWater Marine stock: FY2026 adjusted EBITDA rises 7%
Portillo's stock: Q3 profit outlook rises as weak units face closure